Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis

Table 1

Baseline characteristics of statin users () and matched nonstatin users ().

Characteristics	Statin users number (%)	Matched nonstatin users number (%)
Age		68.16 ± 7.50
<65 years	13 (43.3)	12 (40)	1
≥ 65	17 (56.7)	18 (60)
FIGO stage
III	17 (56.7)	19 (63.3)	0.792
IV	13 (43.3)	11 (36.7)
Tumor grade
G1-G2	9 (30)	4 (13.3)	0.209
G3	21 (70)	26 (86.7)
Histological subtype
Epithelial	4 (13.3)	6 (20)	0.731
Nonepithelial	26 (93.3)	24 (80)
Cytoreductive surgery
Residual tumor > 1 cm	13 (43.3)	14 (46.7)	0.888
Residual tumor ≤ 1 cm	14 (46.7)	14 (46.7)
Not recorded	3 (10)	2 (6.7)
Cycles of chemotherapy
≥6 cycles	27 (90)	25 (83.3)	0.331
Not recorded	2 (6.7)	1 (3.3)
Comorbidities
Hypercholesterolemia	21 (70)	21 (70)	1
Cardiovascular diseases	10 (33.3)	10 (33.3)	1